Faraj Kargoli, MD
Interventional Cardiology · Mesa, AZNPI 1295122638
Payments from drug & device makers
What this record shows
This record is dominated by grants: $88,000 of the $114,876 with a category attached, or 76.6%. Abbott accounts for 70.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $68,787 and has fallen 91.5% since, to $5,845 in 2025. Among interventional cardiology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $403.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$81K
- Medtronic$19K
- Edwards Lifesciences$8K
- Angiodynamics, Inc.$2K
- Abiomed$784
- Boston Scientific$737
- plus $3K from 19 others
What the payments were for
- Grants$88,00077%
- Travel & lodging$9,5928%
- Food & beverage$17,05615%
- Education$2290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 57 | $81,450 |
| Medtronic(2 entities) | 61 | $19,281 |
| Edwards Lifesciences | 92 | $7,584 |
| Angiodynamics, Inc. | 7 | $2,476 |
| Abiomed | 13 | $784 |
| Boston Scientific | 10 | $737 |
| Shockwave Medical, Inc | 6 | $485 |
| Johnson & Johnson | 3 | $370 |
| Amgen | 2 | $250 |
| Cardiovascular Systems Inc. | 2 | $233 |
| Novartis | 10 | $219 |
| Asahi Intecc USA, Inc. | 2 | $172 |
| W. L. Gore & Associates, Inc. | 1 | $140 |
| Boehringer Ingelheim | 1 | $122 |
| Cardiva Medical, Inc. | 1 | $122 |
| Inari Medical, Inc. | 1 | $71 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $66 |
| Penumbra, Inc. | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Cordis US CORP. | 2 | $51 |
| Cleerly, Inc. | 1 | $50 |
| Novo Nordisk | 2 | $35 |
| Biosense Webster, Inc. | 1 | $29 |
| Stryker | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$14,825
- RESOLUTE ONYX$1,829
- PASCAL$1,781
- AlphaVac$1,623
- EVOQUE$1,461
- PERCLOSE PROGLIDE$1,156
- TRICLIP$1,118
- AngioVac$846
- Edwards SAPIEN 3 Transcatheter Heart Valve$825
- OPTIS$690
- MitraClip$592
- Resolute$536
- SAPIEN 3 Ultra RESILIA$434
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$432
- XARELTO$370
- ONYX FRONTIER$319
- Impella$281
- PORTICO$274
- Repatha$250
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$235
How this compares
$114,876 in reported general payments places this provider in the 90th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 30 | $229 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Mesa
- Nachiket PatelMesa$107K
- Satya Prakash AtmakuriMesa$41K
- Robert CandipanMesa$32K
- I-Hui ChiangMesa$27K
- Paul SorajjaPhoenix$1.1M
- Hursh NaikAvondale$781K
- Thomas WaggonerTucson$617K
- Timothy ByrnePhoenix$614K
- Haidar YassinPhoenix$434K
- Kapildeo LotunTucson$365K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.